NCT00392652View on ClinicalTrials.gov

Diindolylmethane in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2009

Conditions
Healthy, no Evidence of Disease
Interventions
DRUG

oral microencapsulated diindolylmethane

Given PO

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00392652 - Diindolylmethane in Healthy Volunteers | Biotech Hunter | Biotech Hunter